Novo Nordisk warned over weaker-than-expected profits amid the recent growth of US rival Eli Lilly’s Mounjaro and Zepbound ...

ADP private payrolls will be closely watched as the US shutdown stifling the flow of official data becomes the longest ever.

Company cuts 9,000 jobs and lowers profit forecast as Wegovy sales slow. Q3 operating profit down 30% on competition ...

Pedersen, Maggie Fick and Bhanvi Satija COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year profit and ...

As Novo Nordisk and Pfizer fight over a promising GLP-1 pipeline at Metsera, Amgen is staying the course on its ...

Arista Networks ( ANET 2.64%) slumped 11% in pre-market trading, even though earnings per share rose 25% after the company ...

The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) ...

Management reassured investors that there could be substantial value in its lead drug candidate, VK2735.

Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues ...

Novo Nordisk once dominated the weight-loss drug market with Wegovy. However, rising competition, particularly from Eli Lilly ...